- Home
- PLSE vs SRAD Comparison
PLSE vs SRAD Comparison
Compare PLSE & SRAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | SRAD |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.9B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLSE | SRAD |
|---|---|---|
| Price | $44.50 | $11.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 23 |
| Target Price | ★ $60.67 | $18.12 |
| AVG Volume (30 Days) | 445.6K | ★ 1.9M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $480.71 | $17.73 |
| Revenue Next Year | $177.98 | $11.77 |
| P/E Ratio | ★ N/A | $49.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $11.39 |
| 52 Week High | $58.90 | $27.85 |
Technical Indicators
Market Signals| Indicator | PLSE | SRAD |
|---|---|---|
| Relative Strength Index (RSI) | 37.52 | 44.23 |
| Support Level | $24.27 | $11.80 |
| Resistance Level | $57.82 | $13.80 |
| Average True Range (ATR) | 3.21 | 0.55 |
| MACD | -0.89 | 0.00 |
| Stochastic Oscillator | 8.16 | 35.76 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
About SRAD Sportradar Group AG
Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing. Geographically, it operates in North America, Africa, AsiaPac & Middle East, Europe, and LATAM & Caribbean.